期刊文献+

螺内酯致乏力和嗜睡

Hypodynamia and lethargy caused by spironolactone
原文传递
导出
摘要 1例24岁男性继发性高血压病患者,为排除原发性醛固酮增多症而接受螺内酯的诊断性治疗,分别于午餐后、晚餐后、次日清晨口服螺内酯各20 mg。第1次服药后约3 h患者突然出现四肢乏力、眩晕、头痛,经卧床休息和吸氧,约30 min后症状缓解。第2次服药后3 h出现乏力。第3次服药后约2 h上述症状复现并伴嗜睡,2 h后自行缓解。停用螺内酯。5 d后患者于晚餐后口服螺内酯20 mg,服药后约2 h以及次日清晨再现眩晕、乏力及嗜睡,后自行缓解。 A 24-year-old male patient with secondary hypertension received a therapeutic trial (diagnostic treatment) with spironolactone in order to exclude primary aldosteronism. He was given oral spironolactone 20 mg after lunch, after dinner and the next morning, respectively. About 3 hours after taking the first dose, the patient developed weakness of limbs, dizziness, and headache. The patient underwent bed rest and oxygen inhalation. About 30 minutes later, his symptoms relieved. Three hours after taking the second dose, he developed weakness. About two hours after taking the third dose, the above-mentioned symptoms recurred, accompanied by lethargy. The symptoms relieved spontaneously 2 hours later. Spironolactone was withdrawn. Five days later, the patient was retreated with oral spironolactone 20 mg after supper. Two hours after the drug use and the next morning, dizziness, hypodynamia, and lethargy recurred. Then, the symptoms relieved spontaneously.
出处 《药物不良反应杂志》 CSCD 2013年第2期113-114,共2页 Adverse Drug Reactions Journal
基金 山东省自然科学基金(ZR2010HL017)
关键词 螺内酯 乏力 嗜睡 Spironolactone Hypodynamia Lethargy
  • 相关文献

参考文献2

  • 1龚艳春,戚文航.继发性高血压的诊断和治疗[J].中国实用内科杂志,2009,29(9):791-795. 被引量:9
  • 2Witham MD, Gillespie ND, Struthers AD. Tolerability of spiro- nolactone in patients with chronic heart failure--a cautionary message. Br J Clin Pharmacol, 2004, 58(5): 554-557.

二级参考文献12

  • 1王志华,初少莉,陈绍行,杜俭,陆旭辉,钱文琪,吴顺娣,郭冀珍,朱鼎良.高血压住院患者病因及危险因素分析[J].高血压杂志,2005,13(8):504-509. 被引量:82
  • 2朱鼎良,龚艳春.继发性高血压的诊断及鉴别诊断[J].继续医学教育,2006,20(1):14-18. 被引量:4
  • 3Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general out patient clinic in Japan [J]. Hypertens Res, 2004,27 : 193 - 202.
  • 4Hanson KJ,Edwards MS,Craven TE,et al. Prevalence of renovascular disease in the elderly :a population-based study [ J ]. J Vase Surg,2002,36:443 - 451.
  • 5Jean WJ,Al-Bitar i,Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease [ J ]. Cathet Cardiovasc Diagn, 1994,32:8 - 10.
  • 6Kaplan NM. The current epidemic of primary aldosteronism : causes and consequences [ J ]. Hypertens,2004,22:863 - 869.
  • 7Gordon RD,Stowasser M, Tunny TJ, et al. High incidence of primary aldosteronism in 199 patients referred with hypertension [ J ]. Clin Exp Pharmacol Physiol, 1994,21:315 - 318.
  • 8Stowasser M. Primary aldosteronism : rare bird or common cause of secondary hypertension ? [ J]. Curr Hypertens Reports,2001 ,86 : 1066 - 1071.
  • 9Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in the primary aldosteronism [ J ]. Surgery, 2004,136 : 1227 - 1235.
  • 10Bravo EL, Tagle R. Pheochromocytoma: State-of-art and future prospects [ J-. Endocrine Rev ,2003,24:539 - 553.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部